Sam-A Pharm. Co. Ltd
Sam-A Pharm. Co., Ltd operates as a pharmaceutical company in South Korea. The company offers a range of pharmaceutical products in the areas of respiratory, anti-biotics, anti-virals, anti-histamines, anti-fungals, dermatology, pain/inflammation, gastrointestinal, cardiovascular, metabolism, urological, and steroids, as well as psychotropic agents; and OTC products in the areas of respiratory, a… Read more
Sam-A Pharm. Co. Ltd (009300) - Total Assets
Latest total assets as of September 2025: ₩246.13 Billion KRW
Based on the latest financial reports, Sam-A Pharm. Co. Ltd (009300) holds total assets worth ₩246.13 Billion KRW as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Sam-A Pharm. Co. Ltd - Total Assets Trend (2009–2024)
This chart illustrates how Sam-A Pharm. Co. Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Sam-A Pharm. Co. Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Sam-A Pharm. Co. Ltd's total assets of ₩246.13 Billion consist of 45.5% current assets and 54.5% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩9.55 Billion | 0.0% |
| Accounts Receivable | ₩20.50 Billion | 8.2% |
| Inventory | ₩14.28 Billion | 5.7% |
| Property, Plant & Equipment | ₩42.75 Billion | 17.2% |
| Intangible Assets | ₩4.19 Billion | 1.7% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2009–2024)
This chart illustrates how Sam-A Pharm. Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Sam-A Pharm. Co. Ltd's current assets represent 45.5% of total assets in 2024, an increase from 42.8% in 2009.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2024, down from 11.7% in 2009.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2009.
- Asset Diversification: The largest asset category is property, plant & equipment at 17.2% of total assets.
Sam-A Pharm. Co. Ltd Competitors by Total Assets
Key competitors of Sam-A Pharm. Co. Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
AGP Ltd
KAR:AGP
|
Pakistan | PKRs28.27 Billion |
|
Sam Chun Dang Pharm. Co. Ltd
KQ:000250
|
Korea | ₩529.96 Billion |
|
DongKoo Bio&Pharma Co. Ltd
KQ:006620
|
Korea | ₩269.00 Billion |
|
NatureCell Co.Ltd
KQ:007390
|
Korea | ₩71.32 Billion |
|
Kyung Dong Pharmaceutical Co. Ltd
KQ:011040
|
Korea | ₩291.47 Billion |
|
WooGene B&G Co. Ltd
KQ:018620
|
Korea | ₩117.10 Billion |
|
Oscotec Inc
KQ:039200
|
Korea | ₩154.14 Billion |
|
EstechPharma Co. Ltd
KQ:041910
|
Korea | ₩192.01 Billion |
Sam-A Pharm. Co. Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Sam-A Pharm. Co. Ltd generates 0.38x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Sam-A Pharm. Co. Ltd generates $8.88 in net profit.
Sam-A Pharm. Co. Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 7.79 | 4.75 | 9.91 |
| Quick Ratio | 6.67 | 4.17 | 8.63 |
| Cash Ratio | 0.00 | 0.66 | 0.00 |
| Working Capital | ₩110.74 Billion | ₩ 86.77 Billion | ₩ 84.40 Billion |
Sam-A Pharm. Co. Ltd - Advanced Valuation Insights
This section examines the relationship between Sam-A Pharm. Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.44 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 7.5% |
| Total Assets | ₩248.73 Billion |
| Market Capitalization | $21.27 Million USD |
Valuation Analysis
Below Book Valuation: The market values Sam-A Pharm. Co. Ltd's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Sam-A Pharm. Co. Ltd's assets grew by 7.5% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Sam-A Pharm. Co. Ltd (2009–2024)
The table below shows the annual total assets of Sam-A Pharm. Co. Ltd from 2009 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩248.73 Billion | +7.53% |
| 2023-12-31 | ₩231.31 Billion | +13.83% |
| 2022-12-31 | ₩203.20 Billion | +7.41% |
| 2021-12-31 | ₩189.17 Billion | +3.88% |
| 2020-12-31 | ₩182.11 Billion | -4.55% |
| 2019-12-31 | ₩190.78 Billion | +9.84% |
| 2018-12-31 | ₩173.69 Billion | +3.40% |
| 2017-12-31 | ₩167.97 Billion | +3.51% |
| 2016-12-31 | ₩162.27 Billion | +6.13% |
| 2015-12-31 | ₩152.91 Billion | +4.83% |
| 2014-12-31 | ₩145.86 Billion | +0.74% |
| 2012-12-31 | ₩144.79 Billion | +5.02% |
| 2011-12-31 | ₩137.86 Billion | +7.08% |
| 2010-12-31 | ₩128.75 Billion | +15.89% |
| 2009-12-31 | ₩111.10 Billion | -- |